Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma

Virchows Archiv

Volumn 440, Issue 6, 2002, Pages 583-588

  Valković, Toni ^a   Dobrila, Frane ^b   Melato, Mauro ^c   Sasso, Franco ^c   Rizzardi, Clara ^c   Jonjić, Nives ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

^b KBC RIJEKA   (Croatia)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Angiogenesis; Breast carcinoma; Tumor associated macrophages; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADJUVANT THERAPY; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CELL ASSAY; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MICROVASCULATURE; MITOSIS RATE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036329210     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280100458     Document Type: Article

References (49)

1. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
2. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis
3. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma
4. Microvessel quantitation and prognosis in invasive breast carcinoma
5. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in kidney and bladder carcinomas
6. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
7. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
8. Vascular permeability factor: A tumor-derivated polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
9. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops
10. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
11. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels
12. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: Experience from a large study with long-term follow up
13. Vascular endothelial growth factor
14. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
15. The implications of angiogenesis for the biology and therapy of cancer metastasis
16. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia
17. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastases and survival in breast cancer
18. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
19. Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma
20. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma
21. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis
22. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma
23. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer
24. Tumor invasion and metastasis: Biochemical mechanisms
25. Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas
26. Tumor microvascularity has no independent prognostic significance for breast cancer
27. Macrophages associated with murine tumor express plasminogen activator activity
28. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF
29. A retrospective cohort study of histologic risk factors in breast cancer patients
30. Vacular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
31. Induction of neovascularisation in vivo and endothelial proliferation in vitro by tumor associated macrophages
32. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice
33. Prognostic significant of HER-2/neu expression in breast cancer and its relationship to other prognostic factors
34. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
35. Pathologic predictors of recurrence in stage I (T1N0M0) breast cancer
36. Expression of vascular endothelial growth factor and its possible relation with neovascularisation in human brain tumors
37. Vascular permeability factor (VPF, VEGF) in tumor biology
38. Evaluation of tumor angiogenesis as a prognostic marker in breast cancer
39. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
40. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer
41. Vascular endothelial growth factor and plated-derivated endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer
42. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
43. Quantitative analysis of vascular endothelial growth factor in primary breast cancer
44. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
45. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphoma
46. Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer
47. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
48. Tumor necrosis factor-alpha as an autocrine and paracrine growth factor for ovarian cancer: Monokine induction of tumor cell proliferation and tumor necrosis factor-alpha expression
49. Tumor necrosis factor in human monocyte-mediated anti tumor cytotoxicity